Código da empresaBIB
Classe de ativosEquity
Gestora do fundoProShares
DomicílioUS
Taxa de administração0.95%
Fundado em2010-04-07
Índice de referênciaNASDAQ / Biotechnology
BIB was created on 2010-04-07 by ProShares. The fund's investment portfolio concentrates primarily on health care equity. BIB provides 2x daily exposure to a modified market-cap-weighted index of biotechnology and pharmaceutical companies listed on NASDAQ.